A randomized phase 3 trial of thalidomide and prednisone (TP) as maintenance therapy following autologous stem cell transplantation (ASCT) in patients with multiple myeloma (MM): An updated analysis of the NCIC Clinical Trials Group MY10 trial. Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Hay, Annette E
  • Trudel, Suzanne
  • Bahlis, Nizar J
  • White, Darrell
  • Sabry, Waleed
  • Belch, Andrew
  • Reiman, Tony J
  • Roy, Jean
  • Shustik, Chaim
  • Kovacs, Michael J
  • Sussman, Jonathan
  • Reece, Donna Ellen
  • Lacy, Martha
  • Meyer, Ralph
  • Shepherd, Lois E
  • Whelan, Kate
  • Zhu, Liting
  • Chapman, Judy-Anne W
  • Stewart, A Keith

publication date

  • May 20, 2014